Does IMIQUIMOD Cause Product packaging quantity issue? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Product packaging quantity issue have been filed in association with IMIQUIMOD (Imiquimod). This represents 0.8% of all adverse event reports for IMIQUIMOD.
14
Reports of Product packaging quantity issue with IMIQUIMOD
0.8%
of all IMIQUIMOD reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product packaging quantity issue From IMIQUIMOD?
Of the 14 reports.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMIQUIMOD. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does IMIQUIMOD Cause?
Off label use (264)
Product use in unapproved indication (179)
Erythema (171)
Drug ineffective (123)
Fatigue (118)
Influenza like illness (101)
Pain (98)
Application site erythema (95)
Nausea (90)
Headache (79)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which IMIQUIMOD Alternatives Have Lower Product packaging quantity issue Risk?
IMIQUIMOD vs IMITREX
IMIQUIMOD vs IMMUNE GLOBULIN NOS
IMIQUIMOD vs IMPLANON
IMIQUIMOD vs INAVOLISIB
IMIQUIMOD vs INCIVEK